Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Irving

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Blood Advances|October 18, 2021
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALLMatthew Greenwood, Toby Trahair, Rosemary Sutton, et al.
Leukemia Research|May 1, 2010
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraDong-Wook Kim, Shripad D Banavali, Udomsak Bunworasate, et al.
Leukemia & Lymphoma|October 7, 2020
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter studyMansi Bhurani, Lorenz Admojo, Carrie Van Der Weyden, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Blood Advances|October 18, 2021
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALLMatthew Greenwood, Toby Trahair, Rosemary Sutton, et al.
Leukemia Research|May 1, 2010
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraDong-Wook Kim, Shripad D Banavali, Udomsak Bunworasate, et al.
Leukemia & Lymphoma|October 7, 2020
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter studyMansi Bhurani, Lorenz Admojo, Carrie Van Der Weyden, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
Pageof 2